United States · FDA National Drug Code directory
Cefadroxil
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 43063-553_2f3a95a9-25cd-d525-e063-6394a90a460f
- Product NDC
- 43063-553
- Form
- CAPSULE
- Composition / generic term
- Cefadroxil
- Labeler
- PD-Rx Pharmaceuticals, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20080423
- Source listing expiry
- 20261231
Source-listed ingredients
- CEFADROXIL — 500 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 10 CAPSULE in 1 BOTTLE, PLASTIC (43063-553-10) · 43063-553-10
- 14 CAPSULE in 1 BOTTLE, PLASTIC (43063-553-14) · 43063-553-14
- 20 CAPSULE in 1 BOTTLE, PLASTIC (43063-553-20) · 43063-553-20
- 28 CAPSULE in 1 BOTTLE, PLASTIC (43063-553-28) · 43063-553-28
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →